GSK Pharma shares surge 14% after Q1 results
The stock rose sharply by 13.91 percent to end at Rs 3,150.90 on BSE.
Jul 24, 2018, 17:40 PM IST
GlaxoSmithKline Pharma Q3 profit dips 33% at Rs 53 crore
GlaxoSmithKline Pharmaceuticals on Saturday reported 32.91 percent decline in net profit at Rs 52.95 crore for the quarter ended December 31, on account of mandatory price cuts as well as demonetisation.
Feb 11, 2017, 17:02 PM IST
GlaxoSmithKline Pharma Q2 net dips 25% at Rs 96 crore
GlaxoSmithKline Pharmaceuticals today reported a 25.39 percent dip in standalone net profit at Rs 96.05 crore for the quarter ended September 30.
Oct 31, 2015, 15:04 PM IST
GSK Pharma completes deal with Novartis Healthcare
The company has completed its transaction with Novartis Healthcare Pvt Ltd Wednesday whereby it has acquired Novartis' vaccines business and divested its marketed oncology portfolio to Novartis India, GlaxoSmithKline Pharmaceuticals said in a filing to the BSE.
Sep 30, 2015, 20:37 PM IST
GSK Pharma's Bengaluru facility to be operational by 2017
GlaxoSmithKline Pharmaceuticals (GSK India) has said its greenfield manufacturing facility at Bengaluru, having an installed capacity of over 9 billion tablets and capsules per year, will be operational by 2017.
Aug 02, 2015, 15:18 PM IST
GlaxoSmithKline appoints Annaswamy Vaidheesh as MD
He would succeed current MD Hasit Joshipura, who is leaving office on August 1, 2015, the company said in a statement.
Jun 22, 2015, 16:11 PM IST
Glaxo considering all options against CCI order
Slapped with a penalty of nearly Rs 61 crore by competition watchdog CCI, GlaxoSmithKline Pharmaceuticals Monday said it would review the order and consider all options, including filing an appeal.
Jun 08, 2015, 22:45 PM IST
GSK Pharma profit up 6.53% at Rs 102.85 cr in Jan-Mar quarter
GlaxoSmithKline Pharmaceuticals Monday reported 6.53 percent increase in standalone net profit at Rs 102.85 crore for the quarter ended March 31, 2015.
May 18, 2015, 17:27 PM IST
GSK Pharma to transfer cancer drug portfolio to Novartis arm
GlaxoSmithKline Pharmaceuticals board on Thursday approved transfer of its cancer drugs portfolio to an arm of Novartis in India in return for acquiring vaccines portfolio as part of a global deal between the two-multinational pharma giants struck last year.
Feb 12, 2015, 21:59 PM IST
